Get started
Cipher Pharmaceuticals Inc.Cipher Pharmaceuticals Inc.Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals Inc.

No trades
See on Supercharts
Overview
Financials News Discussions Forecast Seasonals

PHE chart


Full chart

PHE upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪250.39 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
23.95
Basic EPS (TTM)
0.40 EUR
Net income (FY)
‪10.62 M‬ EUR
Revenue (FY)
‪30.68 M‬ EUR
Shares float
‪14.95 M‬
Beta (1Y)
1.12

About Cipher Pharmaceuticals Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Other
CEO
Craig Mull
Website
cipherpharma.com
Headquarters
Mississauga
Founded
2000
ISIN
CA17253X1050
FIGI
BBG000GMWZ19
Cipher Pharmaceuticals, Inc. engages in a diversified portfolio of commercial and early to late-stage products. It acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products. It offers dermatology products, hospital acute care products, out-licensed products, and specialty medicine. The company was founded on January 9, 2004 and is headquartered in Mississauga, Canada.

Check out other big names from the same industry as PHE.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

PHE news



Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange Cipher Pharmaceuticals Inc. stocks are traded under the ticker PHE.
We've gathered analysts' opinions on Cipher Pharmaceuticals Inc. future price: according to them, PHE price has a max estimate of 12.49 EUR and a min estimate of 8.74 EUR. Watch PHE chart and read a more detailed Cipher Pharmaceuticals Inc. stock forecast: see what analysts think of Cipher Pharmaceuticals Inc. and suggest that you do with its stocks.
PHE reached its all-time high on Feb 21, 2000 with the price of 265.00 EUR, and its all-time low was 0.15 EUR and was reached on Jan 2, 2009. View more price dynamics on PHE chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track Cipher Pharmaceuticals Inc. financials in yearly and quarterly reports right on TradingView.
Cipher Pharmaceuticals Inc. is going to release the next earnings report on Nov 6, 2025. Keep track of upcoming events with our Earnings Calendar.
PHE earnings for the last quarter are 0.19 EUR per share, whereas the estimation was 0.13 EUR resulting in a 39.53% surprise. The estimated earnings for the next quarter are 0.13 EUR per share. See more details about Cipher Pharmaceuticals Inc. earnings.
Cipher Pharmaceuticals Inc. revenue for the last quarter amounts to ‪11.36 M‬ EUR, despite the estimated figure of ‪10.98 M‬ EUR. In the next quarter, revenue is expected to reach ‪11.59 M‬ EUR.
PHE net income for the last quarter is ‪5.09 M‬ EUR, while the quarter before that showed ‪2.42 M‬ EUR of net income which accounts for 110.29% change. Track more Cipher Pharmaceuticals Inc. financial stats to get the full picture.
No, PHE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Cipher Pharmaceuticals Inc. EBITDA is ‪12.35 M‬ EUR, and current EBITDA margin is 27.43%. See more stats in Cipher Pharmaceuticals Inc. financial statements.
Like other stocks, PHE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cipher Pharmaceuticals Inc. stock right from TradingView charts — choose your broker and connect to your account.